Symbol:
TXNDC16
Name:
thioredoxin domain containing 16
RGD ID:
1315553
HGNC Page
HGNC:19965
Description:
Located in endoplasmic reticulum lumen.
Type:
protein-coding
RefSeq Status:
VALIDATED
Previously known as:
ERp90; KIAA1344; thioredoxin domain-containing protein 16
RGD Orthologs
Alliance Orthologs
More Info
more info ...
More Info
Species
Gene symbol and name
Data Source
Assertion derived from
less info ...
Orthologs 1
Mus musculus (house mouse):
Txndc16 (thioredoxin domain containing 16)
HGNC
EggNOG, Ensembl, HGNC, HomoloGene, Inparanoid, NCBI, OMA, OrthoDB, OrthoMCL, Panther, Treefam
Rattus norvegicus (Norway rat):
Txndc16 (thioredoxin domain containing 16)
HGNC
EggNOG, Ensembl, HomoloGene, Inparanoid, NCBI, OMA, OrthoDB, OrthoMCL, Panther, Treefam
Chinchilla lanigera (long-tailed chinchilla):
Txndc16 (thioredoxin domain containing 16)
NCBI
Ortholog
Pan paniscus (bonobo/pygmy chimpanzee):
TXNDC16 (thioredoxin domain containing 16)
NCBI
Ortholog
Canis lupus familiaris (dog):
TXNDC16 (thioredoxin domain containing 16)
HGNC
EggNOG, Ensembl, HomoloGene, Inparanoid, NCBI, OMA, OrthoDB, OrthoMCL, Panther, Treefam
Ictidomys tridecemlineatus (thirteen-lined ground squirrel):
Txndc16 (thioredoxin domain containing 16)
NCBI
Ortholog
Sus scrofa (pig):
TXNDC16 (thioredoxin domain containing 16)
HGNC
Ensembl, NCBI, OrthoDB
Chlorocebus sabaeus (green monkey):
TXNDC16 (thioredoxin domain containing 16)
NCBI
Ortholog
Heterocephalus glaber (naked mole-rat):
Txndc16 (thioredoxin domain containing 16)
NCBI
Ortholog
Other homologs 2
Rattus norvegicus (Norway rat):
Rasa1 (RAS p21 protein activator 1)
HGNC
OMA
Alliance orthologs 3
Rattus norvegicus (Norway rat):
Txndc16 (thioredoxin domain containing 16)
Alliance
DIOPT (Ensembl Compara|HGNC|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Mus musculus (house mouse):
Txndc16 (thioredoxin domain containing 16)
Alliance
DIOPT (Ensembl Compara|HGNC|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Danio rerio (zebrafish):
txndc16 (thioredoxin domain containing 16)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid|ZFIN)
Xenopus tropicalis (tropical clawed frog):
txndc16
Alliance
DIOPT (Ensembl Compara|OMA|OrthoFinder|PANTHER|PhylomeDB)
Xenopus laevis (African clawed frog):
txndc16.L
Alliance
DIOPT (Xenbase)
Allele / Splice:
See ClinVar data
Latest Assembly:
GRCh38 - Human Genome Assembly GRCh38
Position:
Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 14 52,430,596 - 52,552,505 (-) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh38.p14 Ensembl 14 52,429,472 - 52,552,547 (-) Ensembl GRCh38 hg38 GRCh38 GRCh37 14 52,897,314 - 53,019,223 (-) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 14 51,967,059 - 52,088,963 (-) NCBI NCBI36 Build 36 hg18 NCBI36 Celera 14 32,764,912 - 32,886,888 (-) NCBI Celera Cytogenetic Map 14 q22.1 NCBI HuRef 14 33,057,647 - 33,180,093 (-) NCBI HuRef CHM1_1 14 52,836,496 - 52,958,271 (-) NCBI CHM1_1 T2T-CHM13v2.0 14 46,637,669 - 46,760,351 (-) NCBI T2T-CHM13v2.0
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Only show annotations with direct experimental evidence (0 objects hidden)
TXNDC16 Human (+)-schisandrin B multiple interactions ISO Txndc16 (Rattus norvegicus) 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of TXNDC16 mRNA] CTD PMID:31150632 TXNDC16 Human 1,2-dimethylhydrazine multiple interactions ISO Txndc16 (Mus musculus) 6480464 Folic Acid inhibits the reaction [1 and 2-Dimethylhydrazine results in decreased expression of TXNDC16 mRNA] CTD PMID:22206623 TXNDC16 Human 1,2-dimethylhydrazine decreases expression ISO Txndc16 (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in decreased expression of TXNDC16 mRNA CTD PMID:22206623 TXNDC16 Human 17alpha-ethynylestradiol affects expression ISO Txndc16 (Mus musculus) 6480464 Ethinyl Estradiol affects the expression of TXNDC16 mRNA CTD PMID:17555576 TXNDC16 Human 17beta-estradiol multiple interactions ISO Txndc16 (Rattus norvegicus) 6480464 [bisphenol A co-treated with Estradiol] results in increased expression of TXNDC16 mRNA CTD PMID:26496021 TXNDC16 Human 17beta-estradiol decreases expression ISO Txndc16 (Mus musculus) 6480464 Estradiol results in decreased expression of TXNDC16 mRNA CTD PMID:39298647 TXNDC16 Human 17beta-estradiol decreases expression ISO Txndc16 (Rattus norvegicus) 6480464 Estradiol results in decreased expression of TXNDC16 mRNA CTD PMID:32145629 TXNDC16 Human 17beta-hydroxy-5alpha-androstan-3-one increases expression EXP 6480464 Dihydrotestosterone results in increased expression of TXNDC16 mRNA CTD PMID:29581250 TXNDC16 Human 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of TXNDC16 mRNA CTD PMID:20106945 and PMID:21632981 TXNDC16 Human 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Txndc16 (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin results in increased expression of TXNDC16 mRNA CTD PMID:33387578 TXNDC16 Human 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Txndc16 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of TXNDC16 mRNA CTD PMID:24680724 TXNDC16 Human 2,4,6-trinitrobenzenesulfonic acid decreases expression ISO Txndc16 (Mus musculus) 6480464 Trinitrobenzenesulfonic Acid results in decreased expression of TXNDC16 mRNA CTD PMID:17982090 TXNDC16 Human 3,4-methylenedioxymethamphetamine increases expression ISO Txndc16 (Mus musculus) 6480464 N-Methyl-3 and 4-methylenedioxyamphetamine results in increased expression of TXNDC16 mRNA CTD PMID:20188158 TXNDC16 Human 4,4'-sulfonyldiphenol decreases expression ISO Txndc16 (Mus musculus) 6480464 bisphenol S results in decreased expression of TXNDC16 mRNA CTD PMID:39298647 TXNDC16 Human acrylamide increases expression ISO Txndc16 (Rattus norvegicus) 6480464 Acrylamide results in increased expression of TXNDC16 mRNA CTD PMID:28959563 TXNDC16 Human aflatoxin B1 decreases expression ISO Txndc16 (Mus musculus) 6480464 Aflatoxin B1 results in decreased expression of TXNDC16 mRNA CTD PMID:19770486 TXNDC16 Human aflatoxin B1 decreases expression EXP 6480464 Aflatoxin B1 results in decreased expression of TXNDC16 mRNA CTD PMID:27153756 TXNDC16 Human aflatoxin M1 decreases expression EXP 6480464 Aflatoxin M1 results in decreased expression of TXNDC16 mRNA CTD PMID:30928695 TXNDC16 Human all-trans-retinoic acid decreases expression EXP 6480464 Tretinoin results in decreased expression of TXNDC16 mRNA CTD PMID:33167477 TXNDC16 Human amphetamine decreases expression ISO Txndc16 (Rattus norvegicus) 6480464 Amphetamine results in decreased expression of TXNDC16 mRNA CTD PMID:30779732 TXNDC16 Human aristolochic acid A decreases expression EXP 6480464 aristolochic acid I results in decreased expression of TXNDC16 mRNA CTD PMID:33212167 TXNDC16 Human azathioprine decreases expression EXP 6480464 Azathioprine results in decreased expression of TXNDC16 mRNA CTD PMID:22623647 TXNDC16 Human benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of TXNDC16 mRNA CTD PMID:20106945 TXNDC16 Human benzo[a]pyrene affects methylation EXP 6480464 Benzo(a)pyrene affects the methylation of TXNDC16 5' UTR and Benzo(a)pyrene affects the methylation of TXNDC16 intron CTD PMID:27901495 and PMID:30157460 TXNDC16 Human benzo[a]pyrene decreases methylation ISO Txndc16 (Mus musculus) 6480464 Benzo(a)pyrene results in decreased methylation of TXNDC16 intron CTD PMID:27901495 TXNDC16 Human benzo[a]pyrene decreases expression ISO Txndc16 (Mus musculus) 6480464 Benzo(a)pyrene results in decreased expression of TXNDC16 mRNA CTD PMID:19770486 TXNDC16 Human beta-lapachone decreases expression EXP 6480464 beta-lapachone results in decreased expression of TXNDC16 mRNA CTD PMID:38218311 TXNDC16 Human bis(2-ethylhexyl) phthalate decreases expression EXP 6480464 Diethylhexyl Phthalate results in decreased expression of TXNDC16 mRNA CTD PMID:31163220 TXNDC16 Human bisphenol A multiple interactions ISO Txndc16 (Rattus norvegicus) 6480464 [bisphenol A co-treated with Estradiol] results in increased expression of TXNDC16 mRNA CTD PMID:26496021 TXNDC16 Human bisphenol A decreases expression ISO Txndc16 (Rattus norvegicus) 6480464 bisphenol A results in decreased expression of TXNDC16 mRNA CTD PMID:25181051 and PMID:32145629 TXNDC16 Human butanal decreases expression EXP 6480464 butyraldehyde results in decreased expression of TXNDC16 mRNA CTD PMID:26079696 TXNDC16 Human cadmium dichloride decreases expression ISO Txndc16 (Rattus norvegicus) 6480464 Cadmium Chloride results in decreased expression of TXNDC16 mRNA CTD PMID:33453195 TXNDC16 Human carbamazepine affects expression EXP 6480464 Carbamazepine affects the expression of TXNDC16 mRNA CTD PMID:25979313 TXNDC16 Human carbon nanotube decreases expression ISO Txndc16 (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25554681 TXNDC16 Human chlorpyrifos affects expression ISO Txndc16 (Mus musculus) 6480464 Chlorpyrifos affects the expression of TXNDC16 mRNA CTD PMID:37019170 TXNDC16 Human cisplatin increases expression EXP 6480464 Cisplatin results in increased expression of TXNDC16 mRNA CTD PMID:27594783 TXNDC16 Human cyclosporin A decreases expression EXP 6480464 Cyclosporine results in decreased expression of TXNDC16 mRNA CTD PMID:20106945 and PMID:27989131 TXNDC16 Human deoxynivalenol increases phosphorylation ISO Txndc16 (Mus musculus) 6480464 deoxynivalenol results in increased phosphorylation of TXNDC16 protein CTD PMID:23352502 TXNDC16 Human Dibutyl phosphate affects expression EXP 6480464 di-n-butylphosphoric acid affects the expression of TXNDC16 mRNA CTD PMID:37042841 TXNDC16 Human dioxygen multiple interactions ISO Txndc16 (Rattus norvegicus) 6480464 [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of TXNDC16 mRNA CTD PMID:33729688 TXNDC16 Human dorsomorphin multiple interactions EXP 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TXNDC16 mRNA CTD PMID:27188386 TXNDC16 Human epoxiconazole increases expression ISO Txndc16 (Mus musculus) 6480464 epoxiconazole results in increased expression of TXNDC16 mRNA CTD PMID:35436446 TXNDC16 Human ethanol multiple interactions ISO Txndc16 (Mus musculus) 6480464 Ethanol affects the expression of and affects the splicing of TXNDC16 mRNA CTD PMID:30319688 TXNDC16 Human folic acid multiple interactions ISO Txndc16 (Mus musculus) 6480464 Folic Acid inhibits the reaction [1 and 2-Dimethylhydrazine results in decreased expression of TXNDC16 mRNA] CTD PMID:22206623 TXNDC16 Human folic acid decreases expression ISO Txndc16 (Mus musculus) 6480464 Folic Acid results in decreased expression of TXNDC16 mRNA CTD PMID:25629700 TXNDC16 Human gentamycin increases expression ISO Txndc16 (Rattus norvegicus) 6480464 Gentamicins results in increased expression of TXNDC16 mRNA CTD PMID:33387578 TXNDC16 Human methoxychlor affects methylation ISO Txndc16 (Rattus norvegicus) 6480464 Methoxychlor affects the methylation of TXNDC16 gene CTD PMID:35440735 TXNDC16 Human methyl methanesulfonate increases expression EXP 6480464 Methyl Methanesulfonate results in increased expression of TXNDC16 mRNA CTD PMID:23649840 TXNDC16 Human methylmercury chloride increases expression EXP 6480464 methylmercuric chloride results in increased expression of TXNDC16 mRNA CTD PMID:34089799 TXNDC16 Human N-methyl-4-phenylpyridinium increases expression ISO Txndc16 (Rattus norvegicus) 6480464 1-Methyl-4-phenylpyridinium results in increased expression of TXNDC16 mRNA CTD PMID:28801915 TXNDC16 Human nickel atom decreases expression EXP 6480464 Nickel results in decreased expression of TXNDC16 mRNA CTD PMID:24768652 and PMID:25583101 TXNDC16 Human paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of TXNDC16 mRNA CTD PMID:21420995 and PMID:22230336 TXNDC16 Human paracetamol increases expression ISO Txndc16 (Rattus norvegicus) 6480464 Acetaminophen results in increased expression of TXNDC16 mRNA CTD PMID:33387578 TXNDC16 Human paraquat decreases expression ISO Txndc16 (Rattus norvegicus) 6480464 Paraquat results in decreased expression of TXNDC16 mRNA CTD PMID:32680482 TXNDC16 Human pentanal decreases expression EXP 6480464 pentanal results in decreased expression of TXNDC16 mRNA CTD PMID:26079696 TXNDC16 Human perfluorononanoic acid decreases expression EXP 6480464 perfluoro-n-nonanoic acid results in decreased expression of TXNDC16 mRNA CTD PMID:32588087 TXNDC16 Human phenylmercury acetate decreases expression EXP 6480464 Phenylmercuric Acetate results in decreased expression of TXNDC16 mRNA CTD PMID:26272509 TXNDC16 Human phenylmercury acetate multiple interactions EXP 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TXNDC16 mRNA CTD PMID:27188386 TXNDC16 Human pirinixic acid multiple interactions ISO Txndc16 (Mus musculus) 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of TXNDC16 mRNA CTD PMID:19710929 TXNDC16 Human pirinixic acid decreases expression ISO Txndc16 (Mus musculus) 6480464 pirinixic acid results in decreased expression of TXNDC16 mRNA CTD PMID:23811191 TXNDC16 Human quercetin decreases expression EXP 6480464 Quercetin results in decreased expression of TXNDC16 mRNA CTD PMID:21632981 TXNDC16 Human SB 431542 multiple interactions EXP 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TXNDC16 mRNA CTD PMID:27188386 TXNDC16 Human silicon dioxide decreases expression EXP 6480464 Silicon Dioxide analog results in decreased expression of TXNDC16 mRNA CTD PMID:25895662 TXNDC16 Human Soman decreases expression ISO Txndc16 (Rattus norvegicus) 6480464 Soman results in decreased expression of TXNDC16 mRNA CTD PMID:19281266 TXNDC16 Human sunitinib decreases expression EXP 6480464 Sunitinib results in decreased expression of TXNDC16 mRNA CTD PMID:31533062 TXNDC16 Human tamoxifen affects expression ISO Txndc16 (Mus musculus) 6480464 Tamoxifen affects the expression of TXNDC16 mRNA CTD PMID:17555576 TXNDC16 Human testosterone decreases expression ISO Txndc16 (Mus musculus) 6480464 Testosterone results in decreased expression of TXNDC16 mRNA CTD PMID:20600201 and PMID:21669218 TXNDC16 Human tetrachloromethane multiple interactions ISO Txndc16 (Rattus norvegicus) 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of TXNDC16 mRNA] CTD PMID:31150632 TXNDC16 Human tetrachloromethane decreases expression ISO Txndc16 (Rattus norvegicus) 6480464 Carbon Tetrachloride results in decreased expression of TXNDC16 mRNA CTD PMID:31150632 TXNDC16 Human thioacetamide decreases expression ISO Txndc16 (Rattus norvegicus) 6480464 Thioacetamide results in decreased expression of TXNDC16 mRNA CTD PMID:34492290 TXNDC16 Human titanium dioxide decreases methylation ISO Txndc16 (Mus musculus) 6480464 titanium dioxide results in decreased methylation of TXNDC16 promoter alternative form CTD PMID:35295148 TXNDC16 Human trichloroethene increases expression ISO Txndc16 (Rattus norvegicus) 6480464 Trichloroethylene results in increased expression of TXNDC16 mRNA CTD PMID:33387578 TXNDC16 Human trichostatin A affects expression EXP 6480464 trichostatin A affects the expression of TXNDC16 mRNA CTD PMID:28542535 TXNDC16 Human triphenyl phosphate increases expression ISO Txndc16 (Rattus norvegicus) 6480464 triphenyl phosphate results in increased expression of TXNDC16 mRNA CTD PMID:30589522 TXNDC16 Human triptonide increases expression ISO Txndc16 (Mus musculus) 6480464 triptonide results in increased expression of TXNDC16 mRNA CTD PMID:33045310 TXNDC16 Human urethane increases expression EXP 6480464 Urethane results in increased expression of TXNDC16 mRNA CTD PMID:28818685 TXNDC16 Human valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of TXNDC16 mRNA CTD PMID:19101580 and PMID:29154799 TXNDC16 Human valproic acid increases expression ISO Txndc16 (Mus musculus) 6480464 Valproic Acid results in increased expression of TXNDC16 mRNA CTD PMID:21427059 TXNDC16 Human valproic acid affects expression EXP 6480464 Valproic Acid affects the expression of TXNDC16 mRNA CTD PMID:25979313 TXNDC16 Human vinclozolin increases expression ISO Txndc16 (Rattus norvegicus) 6480464 vinclozolin results in increased expression of TXNDC16 mRNA CTD PMID:23034163 and PMID:23869203
(+)-schisandrin B (ISO) 1,2-dimethylhydrazine (ISO) 17alpha-ethynylestradiol (ISO) 17beta-estradiol (ISO) 17beta-hydroxy-5alpha-androstan-3-one (EXP) 2,3,7,8-tetrachlorodibenzodioxine (EXP,ISO) 2,4,6-trinitrobenzenesulfonic acid (ISO) 3,4-methylenedioxymethamphetamine (ISO) 4,4'-sulfonyldiphenol (ISO) acrylamide (ISO) aflatoxin B1 (EXP,ISO) aflatoxin M1 (EXP) all-trans-retinoic acid (EXP) amphetamine (ISO) aristolochic acid A (EXP) azathioprine (EXP) benzo[a]pyrene (EXP,ISO) beta-lapachone (EXP) bis(2-ethylhexyl) phthalate (EXP) bisphenol A (ISO) butanal (EXP) cadmium dichloride (ISO) carbamazepine (EXP) carbon nanotube (ISO) chlorpyrifos (ISO) cisplatin (EXP) cyclosporin A (EXP) deoxynivalenol (ISO) Dibutyl phosphate (EXP) dioxygen (ISO) dorsomorphin (EXP) epoxiconazole (ISO) ethanol (ISO) folic acid (ISO) gentamycin (ISO) methoxychlor (ISO) methyl methanesulfonate (EXP) methylmercury chloride (EXP) N-methyl-4-phenylpyridinium (ISO) nickel atom (EXP) paracetamol (EXP,ISO) paraquat (ISO) pentanal (EXP) perfluorononanoic acid (EXP) phenylmercury acetate (EXP) pirinixic acid (ISO) quercetin (EXP) SB 431542 (EXP) silicon dioxide (EXP) Soman (ISO) sunitinib (EXP) tamoxifen (ISO) testosterone (ISO) tetrachloromethane (ISO) thioacetamide (ISO) titanium dioxide (ISO) trichloroethene (ISO) trichostatin A (EXP) triphenyl phosphate (ISO) triptonide (ISO) urethane (EXP) valproic acid (EXP,ISO) vinclozolin (ISO)
TXNDC16 (Homo sapiens - human)
Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 14 52,430,596 - 52,552,505 (-) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh38.p14 Ensembl 14 52,429,472 - 52,552,547 (-) Ensembl GRCh38 hg38 GRCh38 GRCh37 14 52,897,314 - 53,019,223 (-) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 14 51,967,059 - 52,088,963 (-) NCBI NCBI36 Build 36 hg18 NCBI36 Celera 14 32,764,912 - 32,886,888 (-) NCBI Celera Cytogenetic Map 14 q22.1 NCBI HuRef 14 33,057,647 - 33,180,093 (-) NCBI HuRef CHM1_1 14 52,836,496 - 52,958,271 (-) NCBI CHM1_1 T2T-CHM13v2.0 14 46,637,669 - 46,760,351 (-) NCBI T2T-CHM13v2.0
Txndc16 (Mus musculus - house mouse)
Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm39 14 45,371,905 - 45,457,008 (-) NCBI GRCm39 GRCm39 mm39 GRCm39 Ensembl 14 45,370,922 - 45,457,785 (-) Ensembl GRCm39 Ensembl GRCm38 14 45,134,448 - 45,219,551 (-) NCBI GRCm38 GRCm38 mm10 GRCm38 GRCm38.p6 Ensembl 14 45,133,465 - 45,220,328 (-) Ensembl GRCm38 mm10 GRCm38 MGSCv37 14 45,754,123 - 45,839,069 (-) NCBI GRCm37 MGSCv37 mm9 NCBIm37 MGSCv36 14 44,056,325 - 44,141,271 (-) NCBI MGSCv36 mm8 Celera 14 41,314,858 - 41,399,608 (-) NCBI Celera Cytogenetic Map 14 C1 NCBI cM Map 14 22.77 NCBI
Txndc16 (Rattus norvegicus - Norway rat)
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 15 20,831,541 - 20,905,661 (-) NCBI GRCr8 mRatBN7.2 15 18,351,688 - 18,425,833 (-) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 15 18,351,694 - 18,425,722 (-) Ensembl mRatBN7.2 Ensembl Rnor_6.0 15 19,472,522 - 19,547,384 (-) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 15 19,473,373 - 19,541,815 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 15 23,438,029 - 23,512,690 (-) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 15 21,024,241 - 21,098,469 (-) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 15 21,025,091 - 21,098,469 (-) NCBI Celera 15 18,780,144 - 18,854,497 (-) NCBI Celera Cytogenetic Map 15 p14 NCBI
Txndc16 (Chinchilla lanigera - long-tailed chinchilla)
Chinchilla Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChiLan1.0 Ensembl NW_004955409 10,593,576 - 10,681,465 (+) Ensembl ChiLan1.0 ChiLan1.0 NW_004955409 10,593,693 - 10,680,381 (+) NCBI ChiLan1.0 ChiLan1.0
TXNDC16 (Pan paniscus - bonobo/pygmy chimpanzee)
Bonobo Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl NHGRI_mPanPan1-v2 15 53,561,951 - 53,684,366 (-) NCBI NHGRI_mPanPan1-v2 NHGRI_mPanPan1 14 52,760,890 - 52,900,786 (-) NCBI NHGRI_mPanPan1 Mhudiblu_PPA_v0 14 33,027,634 - 33,149,460 (-) NCBI Mhudiblu_PPA_v0 Mhudiblu_PPA_v0 panPan3 PanPan1.1 14 51,312,237 - 51,433,913 (-) NCBI panpan1.1 PanPan1.1 panPan2 PanPan1.1 Ensembl 14 51,299,416 - 51,425,730 (-) Ensembl panpan1.1 panPan2
TXNDC16 (Canis lupus familiaris - dog)
Dog Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl CanFam3.1 8 28,672,257 - 28,795,401 (-) NCBI CanFam3.1 CanFam3.1 canFam3 CanFam3.1 CanFam3.1 Ensembl 8 28,674,519 - 28,795,356 (-) Ensembl CanFam3.1 canFam3 CanFam3.1 Dog10K_Boxer_Tasha 8 28,417,404 - 28,540,530 (-) NCBI Dog10K_Boxer_Tasha ROS_Cfam_1.0 8 28,839,967 - 28,961,575 (-) NCBI ROS_Cfam_1.0 ROS_Cfam_1.0 Ensembl 8 28,839,985 - 28,961,505 (-) Ensembl ROS_Cfam_1.0 Ensembl UMICH_Zoey_3.1 8 28,512,373 - 28,635,313 (-) NCBI UMICH_Zoey_3.1 UNSW_CanFamBas_1.0 8 28,578,167 - 28,707,403 (-) NCBI UNSW_CanFamBas_1.0 UU_Cfam_GSD_1.0 8 28,914,842 - 29,036,369 (-) NCBI UU_Cfam_GSD_1.0
Txndc16 (Ictidomys tridecemlineatus - thirteen-lined ground squirrel)
Squirrel Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl HiC_Itri_2 NW_024408640 76,474,561 - 76,569,220 (+) NCBI HiC_Itri_2 SpeTri2.0 Ensembl NW_004936697 2,257,486 - 2,344,941 (+) Ensembl SpeTri2.0 SpeTri2.0 Ensembl SpeTri2.0 NW_004936697 2,249,685 - 2,343,297 (+) NCBI SpeTri2.0 SpeTri2.0 SpeTri2.0
TXNDC16 (Sus scrofa - pig)
TXNDC16 (Chlorocebus sabaeus - green monkey)
Green Monkey Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChlSab1.1 24 29,515,739 - 29,619,100 (-) NCBI ChlSab1.1 ChlSab1.1 chlSab2 ChlSab1.1 Ensembl 24 29,513,781 - 29,627,668 (-) Ensembl ChlSab1.1 ChlSab1.1 Ensembl chlSab2 Vero_WHO_p1.0 NW_023666053 17,786,508 - 17,905,158 (-) NCBI Vero_WHO_p1.0 Vero_WHO_p1.0
Txndc16 (Heterocephalus glaber - naked mole-rat)
.
Predicted Target Of
Count of predictions: 822 Count of miRNA genes: 608 Interacting mature miRNAs: 664 Transcripts: ENST00000281741, ENST00000554399, ENST00000555312, ENST00000557374 Prediction methods: Miranda, Rnahybrid, Targetscan Result types: miRGate_prediction
597330170 GWAS1426244_H 6-bromotryptophan measurement QTL GWAS1426244 (human) 3e-21 6-bromotryptophan measurement 14 52514946 52514947 Human 597188217 GWAS1284291_H 6-bromotryptophan measurement QTL GWAS1284291 (human) 2e-20 6-bromotryptophan measurement 14 52457102 52457103 Human 597188218 GWAS1284292_H 6-bromotryptophan measurement QTL GWAS1284292 (human) 8e-89 6-bromotryptophan measurement 14 52514946 52514947 Human 597307166 GWAS1403240_H 6-bromotryptophan measurement QTL GWAS1403240 (human) 2e-58 6-bromotryptophan measurement 14 52514946 52514947 Human 597068528 GWAS1164602_H peripheral arterial disease, traffic air pollution measurement QTL GWAS1164602 (human) 0.000004 peripheral arterial disease, traffic air pollution measurement 14 52494930 52494931 Human 597329852 GWAS1425926_H level of 5-bromotryptophan in blood QTL GWAS1425926 (human) 2e-17 level of 5-bromotryptophan in blood 14 52514946 52514947 Human 406916776 GWAS565752_H obsolete Mendelian syndromes with cleft lip/palate QTL GWAS565752 (human) 0.0000008 obsolete Mendelian syndromes with cleft lip/palate 14 52522510 52522511 Human 597137884 GWAS1233958_H 6-bromotryptophan measurement QTL GWAS1233958 (human) 2e-51 6-bromotryptophan measurement 14 52470537 52470538 Human 597137882 GWAS1233956_H 6-bromotryptophan measurement QTL GWAS1233956 (human) 6e-58 6-bromotryptophan measurement 14 52514946 52514947 Human 597160504 GWAS1256578_H lipid measurement QTL GWAS1256578 (human) 0.000002 lipid measurement blood lipid measurement (CMO:0000050) 14 52492760 52492761 Human 597262443 GWAS1358517_H amino acid measurement QTL GWAS1358517 (human) 0.000002 amino acid measurement 14 52470537 52470538 Human 597086018 GWAS1182092_H serum metabolite measurement QTL GWAS1182092 (human) 5e-13 serum metabolite measurement 14 52514946 52514947 Human 597331180 GWAS1427254_H Tinnitus QTL GWAS1427254 (human) 3e-09 Tinnitus 14 52506598 52506599 Human 597331692 GWAS1427766_H Tinnitus QTL GWAS1427766 (human) 7e-09 Tinnitus 14 52506598 52506599 Human 597279809 GWAS1375883_H 6-bromotryptophan measurement QTL GWAS1375883 (human) 7e-100 6-bromotryptophan measurement 14 52514946 52514947 Human 597334240 GWAS1430314_H rheumatoid arthritis QTL GWAS1430314 (human) 0.000001 rheumatoid arthritis 14 52465166 52465167 Human 597334241 GWAS1430315_H rheumatoid arthritis QTL GWAS1430315 (human) 0.000002 rheumatoid arthritis 14 52455178 52455179 Human 596963562 GWAS1083081_H orofacial cleft QTL GWAS1083081 (human) 0.0000008 orofacial cleft 14 52522510 52522511 Human
G35830
Human Assembly Chr Position (strand) Source JBrowse GRCh37 14 53,016,222 - 53,016,323 UniSTS GRCh37 Build 36 14 52,085,972 - 52,086,073 RGD NCBI36 Celera 14 32,883,809 - 32,883,910 RGD Cytogenetic Map 14 q22.1 UniSTS HuRef 14 33,177,019 - 33,177,120 UniSTS
SHGC-143165
Human Assembly Chr Position (strand) Source JBrowse GRCh37 14 52,952,669 - 52,953,002 UniSTS GRCh37 Build 36 14 52,022,419 - 52,022,752 RGD NCBI36 Celera 14 32,820,256 - 32,820,589 RGD Cytogenetic Map 14 q22.1 UniSTS HuRef 14 33,113,006 - 33,113,339 UniSTS TNG Radiation Hybrid Map 14 14825.0 UniSTS
SHGC-149440
Human Assembly Chr Position (strand) Source JBrowse GRCh37 14 52,988,429 - 52,988,731 UniSTS GRCh37 Build 36 14 52,058,179 - 52,058,481 RGD NCBI36 Celera 14 32,856,016 - 32,856,318 RGD Cytogenetic Map 14 q22.1 UniSTS HuRef 14 33,148,782 - 33,149,084 UniSTS TNG Radiation Hybrid Map 14 14814.0 UniSTS
RH78442
Human Assembly Chr Position (strand) Source JBrowse GRCh37 14 52,897,484 - 52,897,602 UniSTS GRCh37 Build 36 14 51,967,234 - 51,967,352 RGD NCBI36 Celera 14 32,765,088 - 32,765,206 RGD Cytogenetic Map 14 q22.1 UniSTS HuRef 14 33,057,823 - 33,057,941 UniSTS GeneMap99-GB4 RH Map 14 122.63 UniSTS
Click on a value in the shaded box below the category label to view a detailed expression data table for that system.
alimentary part of gastrointestinal system
entire extraembryonic component
1204
2439
2788
2253
4974
1726
2351
6
624
1951
465
2270
7306
6472
53
3734
1
852
1744
1617
175
1
Too many to show, limit is 500. Download them if you would like to view them all.
Ensembl Acc Id:
ENST00000281741 ⟹ ENSP00000281741
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38.p14 Ensembl 14 52,430,596 - 52,552,505 (-) Ensembl
Ensembl Acc Id:
ENST00000554399
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38.p14 Ensembl 14 52,439,259 - 52,552,522 (-) Ensembl
Ensembl Acc Id:
ENST00000555312 ⟹ ENSP00000451619
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38.p14 Ensembl 14 52,430,645 - 52,552,505 (-) Ensembl
Ensembl Acc Id:
ENST00000557374 ⟹ ENSP00000450839
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38.p14 Ensembl 14 52,488,363 - 52,552,505 (-) Ensembl
Ensembl Acc Id:
ENST00000850587 ⟹ ENSP00000520874
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38.p14 Ensembl 14 52,429,472 - 52,552,547 (-) Ensembl
Ensembl Acc Id:
ENST00000850588 ⟹ ENSP00000520875
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38.p14 Ensembl 14 52,430,655 - 52,552,505 (-) Ensembl
RefSeq Acc Id:
NM_001160047 ⟹ NP_001153519
RefSeq Status:
VALIDATED
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38 14 52,430,596 - 52,552,505 (-) NCBI GRCh37 14 52,897,308 - 53,019,301 (-) RGD Celera 14 32,764,912 - 32,886,888 (-) RGD HuRef 14 33,057,647 - 33,180,093 (-) RGD CHM1_1 14 52,836,496 - 52,958,271 (-) NCBI T2T-CHM13v2.0 14 46,637,669 - 46,760,351 (-) NCBI
Sequence:
GAGTCGGTGGCGGCTGCAGGCTGGGAGGGAGAAGTGCTACGCCTTTGCAGGTTGGCGAAGTGGTTCCAGGCTACCCGGCTAGTCTGGCACGGCCCCGTCTTCTGCCTCCTCCTCCGTCGCGTGGCGGC GGGAACTGTTGGCCGCGCGGCCTCGGGAACGGCCCAGGTCCCCGCCCGCAGGTCCCGGGCAGATAACATAGATCATCAGTAGAAAACTTCTTGAAGTTGTTCAAGAAAAATTTGAAAGTAGCAAAATA GAAAATAAAGAATTAACAGCAGATACAGAGGACAGCATGGAAGTGTTGTCTTAGGAAACAGAACACAGCAGTGAAAAAACAGACAAAATCCGCTCAGATACAACTGCAGCTGATAATGTTTTCCGGCT TCAATGTCTTTAGAGTTGGGATCTCTTTTGTCATAATGTGCATTTTTTACATGCCAACAGTAAACTCTTTACCAGAACTGAGTCCTCAGAAATATTTTAGTACATTGCAACCAGGAAAAGCCTCTTTA GCTTATTTTTGTCAAGCTGATTCCCCAAGAACATCTGTATTTCTTGAAGAACTGAATGAGGCTGTTAGACCTCTGCAGGACTATGGAATTTCAGTTGCCAAGGTTAATTGTGTCAAAGAAGAAATATC AAGATACTGTGGAAAAGAAAAGGATTTGATGAAAGCATATTTATTCAAGGGCAACATATTGCTCAGAGAATTCCCTACTGACACCTTGTTTGATGTGAATGCCATTGTCGCCCATGTTCTCTTTGAAG TGAAATATATTACCAACCTGGAAGACCTTCAGAACATAGAAAATGCTCTGAAAGGAAAAGCAAATATTATATTCTCATATGTAAGAGCCATTGGAATACCAGAGCACAGAGCAGTCATGGAAGCCGCT TTTGTGTATGGGACTACATACCAATTTGTCTTAACCACAGAAATTGCCCTTTTGGAAAGTATTGGCTCTGAGGATGTGGAATATGCACATCTCTACTTTTTTCATTGTAAACTAGTCTTGGACTTGAC CCAGCAATGTAGAAGAACACTAATGGAACAGCCATTGACTACACTGAACATTCACCTGTTTATTAAGACAATGAAAGCACCTCTGTTGACTGAAGTTGCTGAAGATCCTCAACAAGTTTCAACTGTCC ATCTCCAACTGGGCTTACCACTGGTTTTTATTGTTAGCCAACAGGCTACTTATGAAGCTGATAGAAGAACTGCAGAATGGGTTGCTTGGCGTCTTCTGGGAAAAGCAGGAGTTCTACTCTTGTTAAGG GACTCTTTGGAAGTGAACATTCCTCAAGATGCTAATGTGGTCTTCAAAAGAGCAGAAGAGGGAGTTCCAGTGGAATTTTTGGTATTACATGATGTTGATTTAATAATATCTCATGTGGAAAATAATAT GCACATTGAGGAAATACAAGAAGATGAAGACAATGACATGGAAGGTCCAGATATAGATGTTCAGGATGATGAAGTGGCAGAAACTGTTTTCAGAGATAGGAAGAGAAAATTACCTTTGGAACTTACAG TGGAACTAACAGAAGAAACATTTAATGCAACAGTGATGGCTTCTGACAGCATAGTACTCTTCTATGCTGGTTGGCAAGCAGTATCCATGGCATTTTTGCAATCCTATATTGATGTGGCAGTTAAACTG AAAGGCACATCTACTATGCTTCTTACTAGAATAAACTGTGCAGATTGGTCTGATGTATGTACTAAGCAAAATGTTACTGAATTTCCTATCATAAAGATGTACAAGAAAGGCGAGAACCCAGTATCTTA TGCTGGAATGTTAGGAACCGAAGATCTCCTAAAATTTATCCAGCTCAACAGGATTTCATATCCAGTGAATATAACATCGATCCAAGAAGCAGAAGAATATTTAAGTGGGGAATTATATAAAGACCTCA TCTTGTATTCTAGTGTGTCAGTATTGGGACTATTTAGTCCAACCATGAAAACAGCAAAAGAAGATTTTAGTGAAGCAGGAAACTACCTAAAAGGATATGTTATCACTGGAATTTATTCTGAAGAAGAT GTTTTGCTACTGTCAACCAAATATGCTGCAAGTCTTCCAGCCCTGCTGCTTGCCAGACACACAGAAGGCAAAATAGAGAGCATCCCACTAGCTAGCACACATGCACAAGACATAGTTCAAATAATAAC AGATGCACTACTGGAAATGTTTCCGGAAATCACTGTGGAAAATCTTCCCAGTTATTTCAGACTTCAGAAACCATTATTGATTTTGTTCAGTGATGGCACTGTAAATCCTCAGTATAAAAAAGCAATAT TGACACTGGTAAAGCAGAAATACTTGGATTCATTTACTCCATGCTGGTTAAATCTAAAGAATACTCCAGTGGGGAGAGGAATCTTGAGGGCATATTTTGATCCTCTGCCTCCCCTTCCTCTTCTTGTT TTGGTGAATCTGCATTCAGGTGGCCAAGTATTTGCATTTCCTTCAGACCAGGCTATAATTGAAGAAAACCTTGTATTGTGGCTGAAGAAATTAGAAGCAGGACTAGAAAATCATATCACAATTTTACC TGCTCAAGAATGGAAACCTCCTCTTCCAGCTTATGATTTTCTAAGTATGATAGATGCCGCAACATCTCAACGTGGCACTAGGAAAGTTCCCAAGTGTATGAAAGAAACAGATGTGCAGGAGAATGATA AGGAACAACATGAAGATAAATCGGCAGTCAGAAAAGAACCGATTGAAACTCTGAGAATAAAGCATTGGAATAGAAGTAATTGGTTTAAAGAAGCAGAAAAATCATTTAGACGTGATAAAGAGTTAGGA TGCTCAAAAGTGAACTAATTTTATAGGGCTGTGGTTTCCAAAATTTTTTTGGCATGATAGACTTAATTTATTTCCTTAAAGAATAATATTAAATCATTTCAAGTTTGCAGACTAGTGCCATCCAATAG AATTATAATATAAGTCACATATTTTATTTAAAATTTTCTAGTAACTACATTAAACAAAGTAAAAGTGAGCAGGGCAAAATAATTTTGATATTACTTTTCACCCAGTAGTATACCCAAAATAGCGAAAT ATAGAAATTATTAATGAGATATTTTACATCCTTTTTTGTACCAAGTCTTCTAAATGCAGTACATATTTTATACTTACTGCATTTCTTACTTCCGAGTAGCCATATTTCAAGTGTTCCTTGCCACATGT GGCCTGTGACTACTGTATTGGACAGTTCAGTACTAGACAAAAACTAGCATAATTAACTTAGTTCTAGCCATGATTTCTATTTGGATTAAAATTAAACTCTAATCACAGTTAACTCCACAGTGCATTCA TGCAGCTGACAGTTATATTTGTTTTATTGGAGTCATGATATTAAAATCAGCGTTTGTCAACCTCAGGGGATATTTAGCAATTGTCGGGAGACATTTTTGATGTCATGACTAGGGCAGTTATTGACATT TAGTGAGTAGAGGCCAGGGATCCTGCTAAATAACCTGCATTGGACAGCGCCCCACAACAAAGAATTATCCTGCCCGAAATGGTAGTCGTGCCAAGGCTGAGTAACCTTGTGTTAAAAGTAACCTGTGG CAGACTAGGTTTCCAGAATTTCCTGGTTCTGCTCACGTATCATGTTTGAAAAAATTTTGGCTATTAAAGATATGTATTAGATGGTCTTATCCTGATTATTACCTGGATACAACTTGATCTTTTCTAAT ATTTTCAGAAAGTGATGGGATAACCCTAGAAGAGGACTCAGAATGATATTTATATTTTAAGTGAGTCTTAAAACCTCCTCTTATTTCTACAAGTTATATGGCTAAATTTCAGATTGAACAGGGATTCA GCATTCTGCCATCTCCTCATGGAAAGAGAGGCTCCCTCATCTGAAGCGTCTCTGAAATCTACCCTTGCAAGCTTCAGACAAATCAGTTGATCTCCCTGAGCCACACGGCCTCATTCTGTGAGGGAGGG AAAGATTAGCCAAAGAGTTAATTTTCATTCCAAATCACTTAGCTGTTAGACTGATCTGTTTGTAGCAGTTGTTTGTCTCATTTTTGCTCTGTGCATTTTTTGAGACATTTGTTGAGAATATTCTATTT GGTGCTCTACTGTATTTTTCTTTTTAATATCTACTTGATATCTTGTTCTTTAAATTTTCTTCACATATGGTTTGCCTGATACAACTGATTTTTATAACTGAAATTTAAGGAATCTAACAGCTAAAACT CAGTAAGTGCATATATTTCCTTATAACATAGACCCGTTGCTACTCTCAGCACCCTCTCCTCAATTTTTTTTCCTGTAGCATGTGATGCCTGATTAAACTCATTTTCATTTGCTTTTATTTCTAATATG GGAACAATGAGAGTGAACTCTAAATATAGGTTGTAGTAATAAAACATCATTAGCCTAATTATTAGAAAATGCTAATTAAGTACCAGCACATAGAAACATGAAATTGCTTAGTCATTGTACCTTTGTCA GCAATTTTGACAGTCATTAATGTTTGTCATAATTTTAAATAAAGTGTCTGGGTTTCAGAATA
hide sequence
RefSeq Acc Id:
NM_020784 ⟹ NP_065835
RefSeq Status:
VALIDATED
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38 14 52,430,596 - 52,552,505 (-) NCBI GRCh37 14 52,897,308 - 53,019,301 (-) RGD Build 36 14 51,967,059 - 52,088,963 (-) NCBI Archive Celera 14 32,764,912 - 32,886,888 (-) RGD HuRef 14 33,057,647 - 33,180,093 (-) RGD CHM1_1 14 52,836,496 - 52,958,271 (-) NCBI T2T-CHM13v2.0 14 46,637,669 - 46,760,351 (-) NCBI
Sequence:
GAGTCGGTGGCGGCTGCAGGCTGGGAGGGAGAAGTGCTACGCCTTTGCAGGTTGGCGAAGTGGT TCCAGGCTACCCGGCTAGTCTGGCACGGCCCCGTCTTCTGCCTCCTCCTCCGTCGCGTGGCGGCGGGAACTGTTGGCCGCGCGGCCTCGGGAACGGCCCAGGTCCCCGCCCGCAGGTCCCGGGCAGAT AACATAGATCATCAGTAGAAAACTTCTTGAAGTTGTTCAAGAAAAATTTGAAAGTAGCAAAATAGAAAATAAAGAATTAACAGCAGATACAGAGGACAGCATGGAAGTGTTGTCTTAGGAAACAGAAC ACAGCAGTGAAAAAACAGACAAAATCCGCTCAGATACAACTGCAGCTGATAATGTTTTCCGGCTTCAATGTCTTTAGAGTTGGGATCTCTTTTGTCATAATGTGCATTTTTTACATGCCAACAGTAAA CTCTTTACCAGAACTGAGTCCTCAGAAATATTTTAGTACATTGCAACCAGGAAAAGCCTCTTTAGCTTATTTTTGTCAAGCTGATTCCCCAAGAACATCTGTATTTCTTGAAGAACTGAATGAGGCTG TTAGACCTCTGCAGGACTATGGAATTTCAGTTGCCAAGGTTAATTGTGTCAAAGAAGAAATATCAAGATACTGTGGAAAAGAAAAGGATTTGATGAAAGCATATTTATTCAAGGGCAACATATTGCTC AGAGAATTCCCTACTGACACCTTGTTTGATGTGAATGCCATTGTCGCCCATGTTCTCTTTGCTCTTCTTTTTAGTGAAGTGAAATATATTACCAACCTGGAAGACCTTCAGAACATAGAAAATGCTCT GAAAGGAAAAGCAAATATTATATTCTCATATGTAAGAGCCATTGGAATACCAGAGCACAGAGCAGTCATGGAAGCCGCTTTTGTGTATGGGACTACATACCAATTTGTCTTAACCACAGAAATTGCCC TTTTGGAAAGTATTGGCTCTGAGGATGTGGAATATGCACATCTCTACTTTTTTCATTGTAAACTAGTCTTGGACTTGACCCAGCAATGTAGAAGAACACTAATGGAACAGCCATTGACTACACTGAAC ATTCACCTGTTTATTAAGACAATGAAAGCACCTCTGTTGACTGAAGTTGCTGAAGATCCTCAACAAGTTTCAACTGTCCATCTCCAACTGGGCTTACCACTGGTTTTTATTGTTAGCCAACAGGCTAC TTATGAAGCTGATAGAAGAACTGCAGAATGGGTTGCTTGGCGTCTTCTGGGAAAAGCAGGAGTTCTACTCTTGTTAAGGGACTCTTTGGAAGTGAACATTCCTCAAGATGCTAATGTGGTCTTCAAAA GAGCAGAAGAGGGAGTTCCAGTGGAATTTTTGGTATTACATGATGTTGATTTAATAATATCTCATGTGGAAAATAATATGCACATTGAGGAAATACAAGAAGATGAAGACAATGACATGGAAGGTCCA GATATAGATGTTCAGGATGATGAAGTGGCAGAAACTGTTTTCAGAGATAGGAAGAGAAAATTACCTTTGGAACTTACAGTGGAACTAACAGAAGAAACATTTAATGCAACAGTGATGGCTTCTGACAG CATAGTACTCTTCTATGCTGGTTGGCAAGCAGTATCCATGGCATTTTTGCAATCCTATATTGATGTGGCAGTTAAACTGAAAGGCACATCTACTATGCTTCTTACTAGAATAAACTGTGCAGATTGGT CTGATGTATGTACTAAGCAAAATGTTACTGAATTTCCTATCATAAAGATGTACAAGAAAGGCGAGAACCCAGTATCTTATGCTGGAATGTTAGGAACCGAAGATCTCCTAAAATTTATCCAGCTCAAC AGGATTTCATATCCAGTGAATATAACATCGATCCAAGAAGCAGAAGAATATTTAAGTGGGGAATTATATAAAGACCTCATCTTGTATTCTAGTGTGTCAGTATTGGGACTATTTAGTCCAACCATGAA AACAGCAAAAGAAGATTTTAGTGAAGCAGGAAACTACCTAAAAGGATATGTTATCACTGGAATTTATTCTGAAGAAGATGTTTTGCTACTGTCAACCAAATATGCTGCAAGTCTTCCAGCCCTGCTGC TTGCCAGACACACAGAAGGCAAAATAGAGAGCATCCCACTAGCTAGCACACATGCACAAGACATAGTTCAAATAATAACAGATGCACTACTGGAAATGTTTCCGGAAATCACTGTGGAAAATCTTCCC AGTTATTTCAGACTTCAGAAACCATTATTGATTTTGTTCAGTGATGGCACTGTAAATCCTCAGTATAAAAAAGCAATATTGACACTGGTAAAGCAGAAATACTTGGATTCATTTACTCCATGCTGGTT AAATCTAAAGAATACTCCAGTGGGGAGAGGAATCTTGAGGGCATATTTTGATCCTCTGCCTCCCCTTCCTCTTCTTGTTTTGGTGAATCTGCATTCAGGTGGCCAAGTATTTGCATTTCCTTCAGACC AGGCTATAATTGAAGAAAACCTTGTATTGTGGCTGAAGAAATTAGAAGCAGGACTAGAAAATCATATCACAATTTTACCTGCTCAAGAATGGAAACCTCCTCTTCCAGCTTATGATTTTCTAAGTATG ATAGATGCCGCAACATCTCAACGTGGCACTAGGAAAGTTCCCAAGTGTATGAAAGAAACAGATGTGCAGGAGAATGATAAGGAACAACATGAAGATAAATCGGCAGTCAGAAAAGAACCGATTGAAAC TCTGAGAATAAAGCATTGGAATAGAAGTAATTGGTTTAAAGAAGCAGAAAAATCATTTAGACGTGATAAAGAGTTAGGATGCTCAAAAGTGAACTAATTTTATAGGGCTGTGGTTTCCAAAATTTTTT TGGCATGATAGACTTAATTTATTTCCTTAAAGAATAATATTAAATCATTTCAAGTTTGCAGACTAGTGCCATCCAATAGAATTATAATATAAGTCACATATTTTATTTAAAATTTTCTAGTAACTACA TTAAACAAAGTAAAAGTGAGCAGGGCAAAATAATTTTGATATTACTTTTCACCCAGTAGTATACCCAAAATAGCGAAATATAGAAATTATTAATGAGATATTTTACATCCTTTTTTGTACCAAGTCTT CTAAATGCAGTACATATTTTATACTTACTGCATTTCTTACTTCCGAGTAGCCATATTTCAAGTGTTCCTTGCCACATGTGGCCTGTGACTACTGTATTGGACAGTTCAGTACTAGACAAAAACTAGCA TAATTAACTTAGTTCTAGCCATGATTTCTATTTGGATTAAAATTAAACTCTAATCACAGTTAACTCCACAGTGCATTCATGCAGCTGACAGTTATATTTGTTTTATTGGAGTCATGATATTAAAATCA GCGTTTGTCAACCTCAGGGGATATTTAGCAATTGTCGGGAGACATTTTTGATGTCATGACTAGGGCAGTTATTGACATTTAGTGAGTAGAGGCCAGGGATCCTGCTAAATAACCTGCATTGGACAGCG CCCCACAACAAAGAATTATCCTGCCCGAAATGGTAGTCGTGCCAAGGCTGAGTAACCTTGTGTTAAAAGTAACCTGTGGCAGACTAGGTTTCCAGAATTTCCTGGTTCTGCTCACGTATCATGTTTGA AAAAATTTTGGCTATTAAAGATATGTATTAGATGGTCTTATCCTGATTATTACCTGGATACAACTTGATCTTTTCTAATATTTTCAGAAAGTGATGGGATAACCCTAGAAGAGGACTCAGAATGATAT TTATATTTTAAGTGAGTCTTAAAACCTCCTCTTATTTCTACAAGTTATATGGCTAAATTTCAGATTGAACAGGGATTCAGCATTCTGCCATCTCCTCATGGAAAGAGAGGCTCCCTCATCTGAAGCGT CTCTGAAATCTACCCTTGCAAGCTTCAGACAAATCAGTTGATCTCCCTGAGCCACACGGCCTCATTCTGTGAGGGAGGGAAAGATTAGCCAAAGAGTTAATTTTCATTCCAAATCACTTAGCTGTTAG ACTGATCTGTTTGTAGCAGTTGTTTGTCTCATTTTTGCTCTGTGCATTTTTTGAGACATTTGTTGAGAATATTCTATTTGGTGCTCTACTGTATTTTTCTTTTTAATATCTACTTGATATCTTGTTCT TTAAATTTTCTTCACATATGGTTTGCCTGATACAACTGATTTTTATAACTGAAATTTAAGGAATCTAACAGCTAAAACTCAGTAAGTGCATATATTTCCTTATAACATAGACCCGTTGCTACTCTCAG CACCCTCTCCTCAATTTTTTTTCCTGTAGCATGTGATGCCTGATTAAACTCATTTTCATTTGCTTTTATTTCTAATATGGGAACAATGAGAGTGAACTCTAAATATAGGTTGTAGTAATAAAACATCA TTAGCCTAATTATTAGAAAATGCTAATTAAGTACCAGCACATAGAAACATGAAATTGCTTAGTCATTGTACCTTTGTCAGCAATTTTGACAGTCATTAATGTTTGTCATAATTTTAAATAAAGTGTCT GGGTTTCAGAATA
hide sequence
RefSeq Acc Id:
XM_017021505 ⟹ XP_016876994
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38 14 52,470,593 - 52,552,505 (-) NCBI
Sequence:
AGCACGAGGAGAAGGAGGAGCTTCGCAGGTTGTTTTTTCCCAGGAGGCCGACTCCGCCGAGTCG GTGGCGGCTGCAGGCTGGGAGGGAGAAGTGCTACGCCTTTGCAGGTTGGCGAAGTGGTTCCAGGCTACCCGGCTAGTCTGGCACGGCCCCGTCTTCTGCCTCCTCCTCCGTCGCGTGGCGGCGGGAAC TGTTGGCCGCGCGGCCTCGGGAACGGCCCAGGTCCCCGCCCGCAGGTCCCGGGCAGATAACATAGATCATCAGTAGAAAACTTCTTGAAGTTGTTCAAGAAAAATTTGAAAGTAGCAAAATAGAAAAT AAAGAATTAACAGCAGATACAGAGGACAGCATGGAAGTGTTGTCTTAGGAAACAGAACACAGCAGTGAAAAAACAGACAAAATCCGCTCAGATACAACTGCAGCTGATAATGTTTTCCGGCTTCAATG TCTTTAGAGTTGGGATCTCTTTTGTCATAATGTGCATTTTTTACATGCCAACAGTAAACTCTTTACCAGAACTGAGTCCTCAGAAATATTTTAGTACATTGCAACCAGGAAAAGCCTCTTTAGCTTAT TTTTGTCAAGCTGATTCCCCAAGAACATCTGTATTTCTTGAAGAACTGAATGAGGCTGTTAGACCTCTGCAGGACTATGGAATTTCAGTTGCCAAGGTTAATTGTGTCAAAGAAGAAATATCAAGATA CTGTGGAAAAGAAAAGGATTTGATGAAAGCATATTTATTCAAGGGCAACATATTGCTCAGAGAATTCCCTACTGACACCTTGTTTGATGTGAATGCCATTGTCGCCCATGTTCTCTTTGCTCTTCTTT TTAGTGAAGTGAAATATATTACCAACCTGGAAGACCTTCAGAACATAGAAAATGCTCTGAAAGGAAAAGCAAATATTATATTCTCATATGTAAGAGCCATTGGAATACCAGAGCACAGAGCAGTCATG GAAGCCGCTTTTGTGTATGGGACTACATACCAATTTGTCTTAACCACAGAAATTGCCCTTTTGGAAAGTATTGGCTCTGAGGATGTGGAATATGCACATCTCTACTTTTTTCATTGTAAACTAGTCTT GGACTTGACCCAGCAATGTAGAAGAACACTAATGGAACAGCCATTGACTACACTGAACATTCACCTGTTTATTAAGACAATGAAAGCACCTCTGTTGACTGAAGTTGCTGAAGATCCTCAACAAGTTT CAACTGTCCATCTCCAACTGGGCTTACCACTGGTTTTTATTGTTAGCCAACAGGCTACTTATGAAGCTGATAGAAGAACTGCAGAATGGGTTGCTTGGCGTCTTCTGGGAAAAGCAGGAGTTCTACTC TTGTTAAGGGACTCTTTGGAAGTGAACATTCCTCAAGATGCTAATGTGGTCTTCAAAAGAGCAGAAGAGGGAGTTCCAGTGGAATTTTTGGTATTACATGATGTTGATTTAATAATATCTCATGTGGA AAATAATATGCACATTGAGGAAATACAAGAAGATGAAGACAATGACATGGAAGGTCCAGATATAGATGTTCAGGATGATGAAGTGGCAGAAACTGTTTTCAGAGATAGGAAGAGAAAATTACCTTTGG AACTTACAGTGGAACTAACAGAAGAAACATTTAATGCAACAGTGATGGCTTCTGACAGCATAGTACTCTTCTATGCTGGTTGGCAAGCAGTATCCATGGCATTTTTGCAATCCTATATTGATGTGGCA GTTAAACTGAAAGTTGTCTGGGGCCATCTTGTCTGCTCCTTACAGCACACATGGCTGGCAGAGAAGGGAAGACAGAGCGGCCATCTTGGAAACGTCTAGTCCTTAGTTCCTGCCGGCACATCTACTAT GCTTCTTACTAGAATAAACTGTGCAGATTGGTCTGATGTATGTACTAAGCAAAATGTTACTGAATTTCCTATCAT
hide sequence
RefSeq Acc Id:
XM_054376461 ⟹ XP_054232436
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source T2T-CHM13v2.0 14 46,677,658 - 46,760,351 (-) NCBI
RefSeq Acc Id:
XR_007064037
Type:
NON-CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38 14 52,457,088 - 52,552,505 (-) NCBI
RefSeq Acc Id:
XR_007064038
Type:
NON-CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38 14 52,457,088 - 52,552,505 (-) NCBI
RefSeq Acc Id:
XR_008488886
Type:
NON-CODING
Position:
Human Assembly Chr Position (strand) Source T2T-CHM13v2.0 14 46,664,150 - 46,760,351 (-) NCBI
RefSeq Acc Id:
XR_008488887
Type:
NON-CODING
Position:
Human Assembly Chr Position (strand) Source T2T-CHM13v2.0 14 46,664,150 - 46,760,351 (-) NCBI
RefSeq Acc Id:
NP_065835 ⟸ NM_020784
- Peptide Label:
isoform 1 precursor
- UniProtKB:
B9EH67 (UniProtKB/Swiss-Prot), A7MD07 (UniProtKB/Swiss-Prot), A7E260 (UniProtKB/Swiss-Prot), A5PKW9 (UniProtKB/Swiss-Prot), Q9H9W7 (UniProtKB/Swiss-Prot), Q9P2K2 (UniProtKB/Swiss-Prot)
- Sequence:
MFSGFNVFRVGISFVIMCIFYMPTVNSLPELSPQKYFSTLQPGKASLAYFCQADSPRTSVFLEELNEAVRPLQDYGISVAKVNCVKEEISRYCGKEKDLMKAYLFKGNILLREFPTDTLFDVNAIVAH VLFALLFSEVKYITNLEDLQNIENALKGKANIIFSYVRAIGIPEHRAVMEAAFVYGTTYQFVLTTEIALLESIGSEDVEYAHLYFFHCKLVLDLTQQCRRTLMEQPLTTLNIHLFIKTMKAPLLTEVA EDPQQVSTVHLQLGLPLVFIVSQQATYEADRRTAEWVAWRLLGKAGVLLLLRDSLEVNIPQDANVVFKRAEEGVPVEFLVLHDVDLIISHVENNMHIEEIQEDEDNDMEGPDIDVQDDEVAETVFRDR KRKLPLELTVELTEETFNATVMASDSIVLFYAGWQAVSMAFLQSYIDVAVKLKGTSTMLLTRINCADWSDVCTKQNVTEFPIIKMYKKGENPVSYAGMLGTEDLLKFIQLNRISYPVNITSIQEAEEY LSGELYKDLILYSSVSVLGLFSPTMKTAKEDFSEAGNYLKGYVITGIYSEEDVLLLSTKYAASLPALLLARHTEGKIESIPLASTHAQDIVQIITDALLEMFPEITVENLPSYFRLQKPLLILFSDGT VNPQYKKAILTLVKQKYLDSFTPCWLNLKNTPVGRGILRAYFDPLPPLPLLVLVNLHSGGQVFAFPSDQAIIEENLVLWLKKLEAGLENHITILPAQEWKPPLPAYDFLSMIDAATSQRGTRKVPKCM KETDVQENDKEQHEDKSAVRKEPIETLRIKHWNRSNWFKEAEKSFRRDKELGCSKVN
hide sequence
RefSeq Acc Id:
NP_001153519 ⟸ NM_001160047
- Peptide Label:
isoform 2 precursor
- UniProtKB:
B7ZME4 (UniProtKB/TrEMBL)
- Sequence:
MFSGFNVFRVGISFVIMCIFYMPTVNSLPELSPQKYFSTLQPGKASLAYFCQADSPRTSVFLEE LNEAVRPLQDYGISVAKVNCVKEEISRYCGKEKDLMKAYLFKGNILLREFPTDTLFDVNAIVAHVLFEVKYITNLEDLQNIENALKGKANIIFSYVRAIGIPEHRAVMEAAFVYGTTYQFVLTTEIAL LESIGSEDVEYAHLYFFHCKLVLDLTQQCRRTLMEQPLTTLNIHLFIKTMKAPLLTEVAEDPQQVSTVHLQLGLPLVFIVSQQATYEADRRTAEWVAWRLLGKAGVLLLLRDSLEVNIPQDANVVFKR AEEGVPVEFLVLHDVDLIISHVENNMHIEEIQEDEDNDMEGPDIDVQDDEVAETVFRDRKRKLPLELTVELTEETFNATVMASDSIVLFYAGWQAVSMAFLQSYIDVAVKLKGTSTMLLTRINCADWS DVCTKQNVTEFPIIKMYKKGENPVSYAGMLGTEDLLKFIQLNRISYPVNITSIQEAEEYLSGELYKDLILYSSVSVLGLFSPTMKTAKEDFSEAGNYLKGYVITGIYSEEDVLLLSTKYAASLPALLL ARHTEGKIESIPLASTHAQDIVQIITDALLEMFPEITVENLPSYFRLQKPLLILFSDGTVNPQYKKAILTLVKQKYLDSFTPCWLNLKNTPVGRGILRAYFDPLPPLPLLVLVNLHSGGQVFAFPSDQ AIIEENLVLWLKKLEAGLENHITILPAQEWKPPLPAYDFLSMIDAATSQRGTRKVPKCMKETDVQENDKEQHEDKSAVRKEPIETLRIKHWNRSNWFKEAEKSFRRDKELGCSKVN
hide sequence
RefSeq Acc Id:
XP_016876994 ⟸ XM_017021505
- Peptide Label:
isoform X1
- Sequence:
MFSGFNVFRVGISFVIMCIFYMPTVNSLPELSPQKYFSTLQPGKASLAYFCQADSPRTSVFLEELNEAVRPLQDYGISVAKVNCVKEEISRYCGKEKDLMKAYLFKGNILLREFPTDTLFDVNAIVAH VLFALLFSEVKYITNLEDLQNIENALKGKANIIFSYVRAIGIPEHRAVMEAAFVYGTTYQFVLTTEIALLESIGSEDVEYAHLYFFHCKLVLDLTQQCRRTLMEQPLTTLNIHLFIKTMKAPLLTEVA EDPQQVSTVHLQLGLPLVFIVSQQATYEADRRTAEWVAWRLLGKAGVLLLLRDSLEVNIPQDANVVFKRAEEGVPVEFLVLHDVDLIISHVENNMHIEEIQEDEDNDMEGPDIDVQDDEVAETVFRDR KRKLPLELTVELTEETFNATVMASDSIVLFYAGWQAVSMAFLQSYIDVAVKLKVVWGHLVCSLQHTWLAEKGRQSGHLGNV
hide sequence
Ensembl Acc Id:
ENSP00000451619 ⟸ ENST00000555312
Ensembl Acc Id:
ENSP00000450839 ⟸ ENST00000557374
Ensembl Acc Id:
ENSP00000281741 ⟸ ENST00000281741
RefSeq Acc Id:
XP_054232436 ⟸ XM_054376461
- Peptide Label:
isoform X1
Ensembl Acc Id:
ENSP00000520875 ⟸ ENST00000850588
Ensembl Acc Id:
ENSP00000520874 ⟸ ENST00000850587
RGD ID: 6791975
Promoter ID: HG_KWN:19382
Type: CpG-Island
SO ACC ID: SO:0000170
Source: MPROMDB
Tissues & Cell Lines: CD4+TCell, CD4+TCell_12Hour, CD4+TCell_2Hour, HeLa_S3, Jurkat, K562, Lymphoblastoid, NB4
Transcripts: NM_001160047, NM_020784, UC010AOE.1
Position: Human Assembly Chr Position (strand) Source Build 36 14 52,088,866 - 52,089,457 (-) MPROMDB
RGD ID: 7227617
Promoter ID: EPDNEW_H19553
Type: initiation region
Name: TXNDC16_1
Description: thioredoxin domain containing 16
SO ACC ID: SO:0000170
Source: EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/ )
Alternative Promoters: null; see alsoEPDNEW_H19554
Experiment Methods: Single-end sequencing.
Position: Human Assembly Chr Position (strand) Source GRCh38 14 52,552,503 - 52,552,563 EPDNEW
RGD ID: 7227615
Promoter ID: EPDNEW_H19554
Type: initiation region
Name: TXNDC16_2
Description: thioredoxin domain containing 16
SO ACC ID: SO:0000170
Source: EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/ )
Alternative Promoters: null; see alsoEPDNEW_H19553
Experiment Methods: Single-end sequencing.; Paired-end sequencing.
Position: Human Assembly Chr Position (strand) Source GRCh38 14 52,552,624 - 52,552,684 EPDNEW